536 results on '"Beekman, Jeffrey M"'
Search Results
2. Repeatability and reproducibility of the Forskolin-induced swelling (FIS) assay on intestinal organoids from people with Cystic Fibrosis
3. Centralized intestinal organoid generation is a feasible and safe approach for personalized medicine as demonstrated in the HIT-CF Europe Organoid Study
4. Exploring intrinsic variability between cultured nasal and bronchial epithelia in cystic fibrosis
5. Readthrough compounds for nonsense mutations: bridging the translational gap
6. Targeted Locus Amplification and Haplotyping
7. Anticodon Engineered Transfer RNAs (ACE-tRNAs) are a Platform Technology for Suppressing Nonsense Mutations
8. Colonization of vancomycin-resistant Enterococcus faecium in human-derived colonic epithelium: Unraveling the transcriptional dynamics of host-enterococcal interactions
9. Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E–CFTR mutation
10. A new era for people with cystic fibrosis
11. Colonization of vancomycin-resistant Enterococcus faecium in human-derived colonic epithelium: Unraveling the transcriptional dynamics of host-enterococcal interactions
12. Repeatability and reproducibility of the Forskolin-induced swelling (FIS) assay on intestinal organoids from people with Cystic Fibrosis
13. OrgaSegment: deep-learning based organoid segmentation to quantify CFTR dependent fluid secretion
14. Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation
15. Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutations
16. Activating alternative chloride channels to treat CF: Friends or Foes?: Report on the Meeting of the Basic Science Working Group in Dubrovnik, Croatia
17. Pharmacological analysis of CFTR variants of cystic fibrosis using stem cell-derived organoids
18. R560S: A class II CFTR mutation that is not rescued by current modulators
19. CFTR modulator theratyping: Current status, gaps and future directions
20. Modulation of the maladaptive stress response to manage diseases of protein folding.
21. Dynamic regulation of airway surface liquid pH by TMEM16A and SLC26A4 in cystic fibrosis nasal epithelia with rare mutations
22. Cystic fibrosis: Beyond the airways. Report on the meeting of the basic science working group in Loutraki, Greece
23. Comparison of ex vivo and in vitro intestinal cystic fibrosis models to measure CFTR-dependent ion channel activity
24. Translational research to enable personalized treatment of cystic fibrosis
25. High-resolution 3D imaging of fixed and cleared organoids
26. Direct Interaction between FcγRI (CD64) and Periplakin Controls Receptor Endocytosis and Ligand Binding Capacity
27. CFTR Function Restoration upon Elexacaftor/Tezacaftor/Ivacaftor Treatment in Patient-Derived Intestinal Organoids with Rare CFTR Genotypes
28. Protocol for generating airway organoids from 2D air liquid interface-differentiated nasal epithelia for use in a functional CFTR assay
29. Biobanking: towards increased access of biomaterials in cystic fibrosis. Report on the pre-conference meeting to the 13th ECFS Basic Science Conference, Pisa, 30 March-2 April, 2016
30. Current and future CFTR therapeutics
31. Airway Epithelial Cultures of Children with Esophageal Atresia as a Model to Study Respiratory Tract Disorders
32. Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19
33. Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis
34. CFTR Function Restoration upon Elexacaftor/Tezacaftor/Ivacaftor Treatment in Patient-Derived Intestinal Organoids with Rare CFTR Genotypes
35. Targeted Locus Amplification and Haplotyping
36. Dynamic regulation of airway surface liquid pH by TMEM16A and SLC26A4 in cystic fibrosis nasal epithelia with rare mutations
37. CFTR Function Restoration upon Elexacaftor/Tezacaftor/Ivacaftor Treatment in Patient-Derived Intestinal Organoids with Rare CFTR Genotypes.
38. Exploring intrinsic variability between cultured nasal and bronchial epithelia in cystic fibrosis
39. Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis
40. High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposing
41. Readthrough compounds for nonsense mutations: bridging the translational gap
42. Protocol for generating airway organoids from 2D air liquid interface-differentiated nasal epithelia for use in a functional CFTR assay
43. Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19
44. Airway Epithelial Cultures of Children with Esophageal Atresia as a Model to Study Respiratory Tract Disorders
45. Targeted Locus Amplification and Haplotyping
46. Potentiator synergy in rectal organoids carrying S1251N, G551D, or F508del CFTR mutations
47. Airway Epithelial Cultures of Children with Esophageal Atresia as a Model to Study Respiratory Tract Disorders
48. Long‐term expanding human airway organoids for disease modeling
49. Establishment and characterization of a newPseudomonas aeruginosainfection model using 2D airway organoids and dual RNA sequencing
50. An inducible mouse model for microvillus inclusion disease reveals a role for myosin Vb in apical and basolateral trafficking
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.